Baker Bros. Advisors Lp Bellicum Pharmaceuticals, Inc (BLCM) insider trading activity

BAKER BROS. ADVISORS LP Transaction History

Date	Transaction	Value	Shares Traded
Nov 22 2023	BUY Exercise of in-the-money or at-the-money derivatives securities	-	2,116,349
Jan 19 2018	SELL Open market or private sale	$2,336,305 $7.91 p/Share	295,361
Jan 18 2018	SELL Open market or private sale	$2,637,165 $8.12 p/Share	324,774
Jan 17 2018	SELL Open market or private sale	$2,248,978 $8.63 p/Share	260,600

Also insider at

INCY

INCYTE CORP Healthcare

GHDX

GENOMIC HEALTH INC

Director

IDRA

IDERA PHARMACEUTICALS, INC. Healthcare

> 10% Shareholder

RYTM

RHYTHM PHARMACEUTICALS, INC. Healthcare

BGNE

BeiGene, Ltd. Healthcare

ACAD

ACADIA PHARMACEUTICALS INC Healthcare

MRTX

Mirati Therapeutics, Inc. Healthcare

SGEN

Seagen Inc. Healthcare

Director

NVTA

Invitae Corp Healthcare

> 10% Shareholder

ALXN

ALEXION PHARMACEUTICALS, INC.

Director

NLTX

Neoleukin Therapeutics, Inc. Healthcare

Director

KNSA

Kiniksa Pharmaceuticals, Ltd. Healthcare

KOD

Kodiak Sciences Inc. Healthcare

HOOK

HOOKIPA Pharma Inc. Healthcare

BCEL

Atreca, Inc. Healthcare

IGMS

IGM Biosciences, Inc. Healthcare

ZYME

Zymeworks Inc. Healthcare

Director

PRLD

Prelude Therapeutics Inc Healthcare

TLIS

Talis Biomedical Corp Healthcare

Director

AGLE

Aeglea BioTherapeutics, Inc. Healthcare

Director

TCRX

TScan Therapeutics, Inc. Healthcare

TRDA

Entrada Therapeutics, Inc. Healthcare

DBVT

DBV Technologies S.A. Healthcare

Director

MDGL

MADRIGAL PHARMACEUTICALS, INC. Healthcare

VTVT

vTv Therapeutics Inc. Healthcare

KYMR

Kymera Therapeutics, Inc. Healthcare

BCYC

BICYCLE THERAPEUTICS plc Healthcare

IMCR

Immunocore Holdings plc Healthcare

BBA